News Daily News Información Pública de Datos: Los Cambios de Política de Nueva York Podrían Haber Aumentado los Índices PCI de IM Complicados con Shocks Cardiogénicos Todd Neale July 28, 2016
News Opinion Fellow Talk Hemodynamics Galore: What I Learned at the C3 Summit Tiffany Patterson, MBBS July 27, 2016
News Daily News US Government Proposes Fixed Payments for ‘Total Experience’ of MI Care, CABG Caitlin E. Cox July 26, 2016
News Daily News FDA: Angiographic Catheter Recalled Due to Potential Tip Separation Todd Neale July 22, 2016
Presentation Readmission After Inpatient PCI in the Medicare Population Presenter: Christian McNeely July 21, 2016
News Daily News Decline Seen in Readmissions After PCI in the Medicare Population Todd Neale July 21, 2016
News Daily News Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor Shelley Wood July 20, 2016
News Daily News Public Reporting Should Focus on Institutions or Teams, Not Individuals, CV Surgeons Say L.A. McKeown July 13, 2016
News Daily News FDA: No More Chances for Embattled Coagulation Monitoring System Todd Neale July 13, 2016
News Daily News FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación Todd Neale July 13, 2016
News Daily News Cardiology’s Wage Gap: Time to ‘Own the Problem and Fix It,’ Experts Say Shelley Wood July 12, 2016
News Daily News Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients Yael L. Maxwell July 05, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016
News Daily News Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls Shelley Wood July 05, 2016
News Daily News Los Dispositivos Médicos Aprobados Más Rápidamente en la UE son Objeto de Más Alertas de Seguridad y Nuevas Inspecciones Shelley Wood July 05, 2016
News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016